| |
| |
|
| Insider
Information: |
Stack David M |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
186,481 |
|
|
Indirect Shares
|
156,184 |
|
|
| Direct
Value |
$5,747,344 |
|
|
|
Indirect Value
|
$3,615,591 |
|
|
| Total
Shares |
342,665 |
|
|
| Total
Value |
$9,362,935 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
5
|
|
Stock
price went up :
|
1
|
3
|
| Stock
price went down : |
3
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
| Percentage
Gain/Loss : |
 -15.8%
|
 67.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pacira Pharmaceuticals, Inc. |
PCRX |
CEO and Chairman, Dire... |
2023-06-14 |
186,481 |
2023-06-14 |
116,184 |
Premium* |
|
|
Amarin Corp Plc |
AMRN |
Director |
2019-05-29 |
0 |
2021-06-04 |
40,000 |
Premium* |
|
|
Chiasma, Inc |
CHMA |
Director |
2020-11-30 |
0 |
2021-08-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
124 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2019-08-15 |
4 |
AS |
$39.05 |
$503,092 |
D/D |
(12,849) |
156,299 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2019-08-15 |
4 |
OE |
$10.81 |
$138,898 |
D/D |
12,849 |
169,148 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2019-09-18 |
4 |
OE |
$1.61 |
$47,760 |
D/D |
14,000 |
170,299 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2019-10-02 |
4 |
OE |
$1.61 |
$66,170 |
D/D |
17,000 |
187,299 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2019-11-15 |
4 |
AS |
$42.81 |
$1,926,450 |
D/D |
(45,000) |
142,299 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2019-11-15 |
4 |
OE |
$10.81 |
$270,250 |
I/I |
25,000 |
26,208 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2019-11-15 |
4 |
AS |
$42.81 |
$1,070,250 |
I/I |
(25,000) |
1,208 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2019-12-26 |
4 |
OE |
$1.61 |
$71,000 |
D/D |
20,000 |
162,299 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2020-01-15 |
4 |
OE |
$10.81 |
$270,250 |
I/I |
25,000 |
26,208 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2020-01-15 |
4 |
AS |
$42.61 |
$1,066,968 |
I/I |
(25,000) |
1,208 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2020-02-21 |
4 |
OE |
$1.61 |
$121,189 |
D/D |
35,856 |
198,334 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2020-06-04 |
4 |
S |
$46.33 |
$663,182 |
D/D |
(14,314) |
184,020 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2020-06-08 |
4 |
S |
$48.08 |
$823,402 |
D/D |
(17,111) |
166,909 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2020-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
33,300 |
200,209 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2020-07-15 |
4 |
AS |
$56.88 |
$682,560 |
D/D |
(12,000) |
188,377 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2020-08-17 |
4 |
AS |
$61.79 |
$928,619 |
D/D |
(15,000) |
173,377 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2020-10-14 |
4 |
OE |
$10.81 |
$324,300 |
D/D |
30,000 |
203,377 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2020-10-14 |
4 |
AS |
$55.53 |
$1,665,900 |
D/D |
(30,000) |
173,377 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2020-10-15 |
4 |
AS |
$55.00 |
$1,650,000 |
D/D |
(30,000) |
173,377 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2020-10-15 |
4 |
OE |
$10.81 |
$324,300 |
D/D |
30,000 |
203,377 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2020-10-16 |
4 |
OE |
$10.81 |
$324,300 |
D/D |
30,000 |
203,377 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2020-10-16 |
4 |
AS |
$55.56 |
$1,666,800 |
D/D |
(30,000) |
173,377 |
0 |
% |
|
| CHMA |
Chiasma, Inc |
Director |
– • – |
2020-11-30 |
4 |
B |
$4.27 |
$106,858 |
I/I |
25,000 |
25,000 |
2.1 |
% |
|
| AMRN |
Amarin Corp Plc |
Director |
– • – |
2020-11-30 |
4 |
B |
$4.86 |
$121,518 |
I/I |
25,000 |
25,000 |
2.1 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2021-02-02 |
4 |
AS |
$68.41 |
$1,474,874 |
D/D |
(21,250) |
76,061 |
0 |
% |
|
124 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
